Xolair is a branded injectable medication used to treat allergic asthma, chronic hives, and rhinosinusitis. It’s recently been approved to manage food allergies, reducing the risk of serious reactions ...
About 20 million people in the U.S.—including four million children—have food allergies. Now, there's a new way to reduce their risk of severe allergic reactions. A study published in the New England ...
Please provide your email address to receive an email when new articles are posted on . The campaign follows the approval of Xolair for the reduction of allergic reactions after accidental exposure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback